CareDx Completes Acquisition of Cancer Diagnostic Company
The deal adds a blood-based test for viral-mediated cancers to the company’s portfolio of transplant and cell therapy services.
Category: Company News
Company News
Latest
Company News
Latest
Siemens Healthineers Launches New Hematology Analyzer for US Laboratories
The Atellica HEMA 580 is designed for mid- to high-volume labs to automate testing workflows and reduce preanalytical variability.
Company News
Latest
Allarity Secures US Patent for Ovarian Cancer Companion Diagnostic Test
The patent covers a gene-expression profiling method designed to identify patients most likely to respond to the investigational therapy stenoparib through 2042.
Early Lung Cancer Blood Test Completes US Laboratory Validation
The CIZ1B biomarker assay is designed to complement LDCT screening by helping assess lung cancer risk and clarify indeterminate findings.
Read More
Agilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows
Agilent Technologies has partnered with OpenAI and Boston Consulting Group to accelerate artificial intelligence deployment in lab workflows, aiming to deliver faster scientific insights and advance intelligent instruments, software, and services.
Read More
Labcorp Expands DPYD Test to Identify Chemotherapy Toxicity Risk
The updated test includes additional DPYD variants recommended by the Association for Molecular Pathology to help identify patients who may be at risk for severe chemotherapy side effects.
Read More
Tempus Launches Open-Source Digital Pathology Consortium with Major Medical Centers
The initiative aims to standardize digital pathology through an open-source platform and image management system.
Read More
Diazyme Laboratories Acquires Carolina Liquid Chemistries
Diazyme Laboratories has acquired Carolina Liquid Chemistries, integrating CLC’s chemistry systems and reagents with Diazyme’s diagnostic technologies to expand solutions for reference and clinical laboratories.
Read More
Thermo Fisher Scientific Launches New DNA and RNA Analysis System
The integrated electrophoresis solution is designed to simplify routine verification by eliminating gel casting and buffer preparation.
Read More
Volta Labs Launches Automated Library Prep for Oxford Nanopore Sequencing Kits
The Callisto Sample Prep System application is optimized for the PromethION platform to support whole genome sequencing workflows.
Read More
Agilent Launches New Trace Element Analysis System for Laboratories
The new triple quadrupole mass spectrometry system aims to increase sample throughput and simplify interference removal.
Read More
Noom Launches At-Home Blood Test Kit for Metabolic Health Tracking
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read More
ClearNote Health Raises $52 Million for Early Cancer Detection Tests
The funding will support commercial expansion of the company’s blood-based diagnostic tests and the appointment of a new president and chief operating officer.
Read More
Beckman Coulter Launches New Acoustic Liquid Handlers for High-Throughput Labs
Beckman Coulter Life Sciences has released the Echo 650 Plus Series acoustic liquid handlers, featuring next-generation electronics and a 54% reduction in power consumption for high-throughput labs, according to the company.
Read More
Roche to Acquire PathAI to Expand Digital Pathology and AI Diagnostics
The $750 million deal aims to integrate AI-powered technology and image management systems into pathology laboratory workflows.
Read More
Cenevo Adds Natural Language Search to Mosaic Lab Inventory Platform
Cenevo has introduced an AI-powered natural language search feature to its Mosaic lab inventory platform, enabling scientists to locate samples using plain language queries while maintaining data traceability.
Read More
Co-Diagnostics Develops Strategy for Ebola Bundibugyo Virus Assay
Co-Diagnostics has completed its assay development strategy for Bundibugyo virus, following the WHO’s emergency declaration and CDC’s updated traveler screening measures amid ongoing Ebola outbreaks in the DRC and Uganda.
Read More
Tempus Launches AI-Powered Prostate Cancer Test for Metastatic Patients
Tempus has launched the ArteraAI Prostate Test, a CLIA-certified, CAP-accredited AI tool for metastatic hormone-sensitive prostate cancer, offering personalized risk estimates and designed to support treatment decisions, according to the company.
Read More